HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $665 | -100.0% | 45,000 | -96.7% | 0.00% | -97.5% |
| Q4 2021 | $47,764,000 | +12147.2% | 1,361,573 | +12538.8% | 0.12% | +12000.0% |
| Q3 2021 | $390,000 | +27.5% | 10,773 | +17.1% | 0.00% | 0.0% |
| Q2 2021 | $306,000 | +14.6% | 9,200 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $267,000 | -24.4% | 9,500 | -15.2% | 0.00% | 0.0% |
| Q4 2020 | $353,000 | -80.6% | 11,200 | -80.0% | 0.00% | -75.0% |
| Q3 2020 | $1,817,000 | +18.1% | 56,000 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $1,538,000 | +53.2% | 56,000 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $1,004,000 | +254.8% | 56,000 | +400.0% | 0.00% | +300.0% |
| Q4 2019 | $283,000 | -18.9% | 11,200 | -1.8% | 0.00% | 0.0% |
| Q1 2019 | $349,000 | +53.7% | 11,400 | -33.7% | 0.00% | 0.0% |
| Q1 2016 | $227,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |